Table 2 Pathological characteristics for the uterine component of the concurrent ovarian and uterine cancer patients (n=24)

From: The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review

Stage

n (%)

IA

15 (62.5)

1B

3 (12.5)

IC

2 (8.3)

II

2 (8.3)

IIIC2

1 (4.2)

IVB

1 (4.2)

Histology

 Endometrioid

15 (62.5)

 UPSC

4 (16.7)

 Clear cell

3 (12.5)

 Adenocarcinoma

2 (8.3)

Grade

 G1

6 (25.0)

 G2

9 (41.7)

 G3

8 (33.3)

Lymphovascular space involvement

 Yes

5 (20.8)

 No

19 (79.2)